Siemens Healthineers to sell $140 million in medical equipment to Atrium Health
Reuters
Published Nov 28, 2022 20:20
Updated Nov 28, 2022 21:36
By Bianca Flowers
CHICAGO (Reuters) - Siemens Healthineers on Monday announced an agreement to sell more than $140 million dollars of medical equipment to U.S. healthcare provider Atrium Health over the next 10 years in an effort to increase access to care in underserved communities.
The agreement with Atrium, which is focused in the U.S. Southeast, marks the 15th long-term partnership that the German company has entered with a U.S. customer.
"It is a method to equip Atrium step by step with the right fleet of technology," Siemens Healthineers Chief Executive Bernd Montag told Reuters in an interview on the sidelines of a radiology conference in Chicago.
"It's about educating surgeons and showing them new techniques, and rolling out the technologies across the Atrium system and look at how you can operate more efficiently."
The news comes after Siemens Healthineers told shareholders at its fiscal year-end meeting that it will restructure its diagnostic division to save around 300 million euros ($302 million) each year starting in 2025.
Montag confirmed that there will be layoffs as a result but declined to comment on how many employees will be impacted by job cuts.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.